Slideshow
Author(s):
Parkinson disease articles published in 2018 reveal deeper dives into factors that include the impact of sleep and fatigue on symptoms.
FDA Approves Apomorphine Infusion Device SPN-830 as New Parkinson Treatment
Episode 132: Aiding Diagnosis of Synucleinopathies Through SAAmplify-aSYN Biomarker Test
Advancing Neurology Through Compassion and Innovation: Insights from Dr. Hubble
Neurology Unwrapped: 2024’s Most Intriguing Conversations
Updates in Therapeutic Development: Clinical Trial Readouts to Watch in the First Half of 2025
NeuroVoices: Daniel Harrison, MD, on Defining APP Competencies in Neurocritical Care Teams